Dysfunction of the proximal tubule (PT) is associated with variable degrees of solute wasting and low-molecular-weight proteinuria. We measured metabolic consequences and adaptation mechanisms in a model of inherited PT disorders using PT cells of ClC-5-deficient (Clcn5Y/À) mice, a wellestablished model of Dent's disease. Compared to cells taken from control mice, those from the mutant mice had increased expression of markers of proliferation (Ki67, proliferative cell nuclear antigen (PCNA), and cyclin E) and oxidative scavengers (superoxide dismutase I and thioredoxin). Transcriptome and protein analyses showed fourfold induction of type III carbonic anhydrase in a kidney-specific manner in the knockout mice located in scattered PT cells. Kidney-specific carbonic anhydrase type III (CAIII) upregulation was confirmed in other mice lacking the multiligand receptor megalin and in a patient with Dent's disease due to an inactivating CLCN5 mutation. The type III enzyme was specifically detected in the urine of mice lacking ClC-5 or megalin, patients with Dent's disease, and in PT cell lines exposed to oxidative stress. Our study shows that lack of PT ClC-5 in mice and men is associated with CAIII induction, increased cell proliferation, and oxidative stress.
The epithelial cells lining the proximal tubule (PT) segment of the kidney play an essential role in reabsorbing solutes filtrated by the glomeruli. In particular, PT cells reabsorb albumin and low-molecular-weight (LMW) proteins through an active endocytic pathway that involves two multiligandbinding receptors, megalin and cubilin, which are abundantly expressed at the brush border. 1 Upon ligand binding, the receptors interact and are internalized into coated vesicles, with subsequent delivery to endosomes and lysosomes for ligand processing and receptor recycling. This endocytic trafficking involves the progressive acidification of the endosome-lysosome pathway in PT cells, a process driven by the vacuolar H þ -ATPase (V-ATPase) complex. 2 The generalized dysfunction of the PT, named 'renal Fanconi syndrome,' is associated with variable degrees of solute wasting and LMW proteinuria, which can lead to severe clinical manifestations, such as growth retardation, rickets, nephrocalcinosis, and renal failure. Recent insights into rare inherited disorders show the importance of receptor-mediated endocytosis in the pathophysiology of PT dysfunction. Inactivating mutations in the CLCN5 gene, which encodes the endosomal Cl À /H þ exchanger ClC-5, are associated with Dent's disease, an X-linked renal Fanconi syndrome associated with hypercalciuria nephrocalcinosis, nephrolithiasis, and renal failure in some patients. 3 ClC-5 is primarily localized in PT cell endosomes, where it co-distributes with the V-ATPase. 4, 5 Genetic inactivation of Clcn5 in mice causes renal tubular defects that mimic human Dent's disease, including severe PT dysfunction with impaired endocytosis and trafficking defects of megalin and cubilin leading to LMW proteinuria. [6] [7] [8] Similarly, the functional loss of cubilin in Imerslund-Gräsbeck disease 9 or the genetic inactivation of megalin (Lrp2) in mice 10 lead to PT dysfunction with LMW proteinuria.
The biochemical and metabolic outcomes of the PT cell dysfunction associated with inherited renal Fanconi syndrome and the adaptative mechanisms potentially involved remain poorly understood. Recently, Wilmer et al. 11 have reported an increased oxidative stress and altered redox status in PT cells cultured from the urine of patients with cystinosis, a major cause of inherited renal Fanconi syndrome, suggesting that PT dysfunction may be associated with oxidative stress. In this study, we have used Clcn5 knockout (KO) mice as a well-defined model of Dent's disease and generalized renal Fanconi syndrome 6, 7 to investigate the metabolic consequences and adaptative mechanisms of PT dysfunction. The Clcn5 Y/À kidneys were characterized by higher cell proliferation and oxidative stress, and the induction of type III carbonic anhydrase (CAIII)-an early mesodermal marker with the lowest hydratase activity of the CA isoforms and no documented role in the kidney. 12 CAIII was exclusively distributed in scattered PT cells and was excreted in Clcn5 Y/À urine. These data were confirmed in patients with Dent's disease and investigated in other mouse models of PT dysfunction and PT cell lines exposed to oxidant conditions. Taken together, these observations suggest that generalized PT dysfunction due to the loss of ClC-5 is associated with increased cell proliferation, dedifferentiation, and oxidative stress. Our in vitro studies in PT cells support the hypothesis that CAIII production may play a role in response to oxidative damage.
RESULTS

Proliferation and oxidative stress in Clcn5
Y/À kidneys
Real-time reverse transcription-PCR (RT-PCR) analyses ( Figure 1 ) showed a significant increase in the expression of proliferative cell nuclear antigen (PCNA), Ki67, cyclin E, and osteopontin in the kidneys of Clcn5 Y/À mice. Distinct reactive oxygen species scavengers, such as type I superoxide dismutase and thioredoxin, were also upregulated, suggesting the solicitation of cell oxidative defenses in Clcn5 Y/À kidneys ( Figure 1 ). These results, obtained in 12-week-old mice, were also observed in 1-year-old Clcn5 Y/À mice (data not shown). Immunohistochemistry detected a 3.5-fold increase in the number of PCNA-and Ki67-positive cells in ClC-5-deficient kidneys (B1.8% of PT cells) vs controls (B0.5% of PT cells) ( Figure 2 ). Comparative measurement of ethidium fluorescence in kidney sections revealed that the lack of ClC-5 was associated with a major increase in the production of superoxide O 2 K -anion in PT cells ( Figure 2 ). These observations showed that the generalized PT dysfunction due to the loss of ClC-5 is reflected by significant cell proliferation and a major oxidative stress that solicitates reactive oxygen species scavengers.
Comparison of Clcn5
Y/ þ and Clcn5 Y/À renal transcriptomes
We next used the amplified fragment length polymorphism (AFLP) procedure to identify genes possibly involved in adaptative mechanisms against PT dysfunction. Using onethird of the possible AFLP primer combinations (see Materials and Methods), a total of 10 cDNA bands were identified as differentially expressed in 12-week-old Clcn5
One of these bands, significantly upregulated in Clcn5 Y/À samples, was identified as a transcript of Car3 (GenBank accession no. M27796), encoding CAIII. The other cDNA bands, which were differentially expressed in Clcn5 Y/À kidneys, corresponded to unidentified mouse contigs. Quantitative real-time RT-PCR was used to validate these results by comparing the mRNA expression of CAIII and CAII, the most abundant CA isoform in the kidney (Figure 3a) . The CAIII mRNA expression was approximately fivefold lower than CAII in wild-type kidneys. However, the CAIII transcript was significantly upregulated in ClC-5-deficient kidneys (ratio: 553±48% of Clcn5 Y/ þ level, n ¼ 6), whereas CAII mRNA expression remained unchanged (94 ± 8% of Clcn5 Y/ þ level). A similar induction of CAIII expression was also observed in 1-year-old Clcn5 Y/À kidneys, and the results were confirmed on laser capture microdissected cortex samples (data not shown). The upregulation of CAIII mRNA associated with the loss of ClC-5 was specific to the kidney, as CAIII mRNA expression levels in liver, skeletal muscle (vastus lateralis), and lung from Clcn5 Y/À mice were unchanged (Figure 3b ). These data, obtained using AFLP coupled with real-time RT-PCR, evidenced a significant and kidney-specific induction of Car3 mRNA expression in mice lacking ClC-5.
Expression of CAIII in Clcn5 kidney and urine
Affinity-purified anti-CAIII antibodies, with no crossreactivity for purified CAI and CAII, 13 were used to further investigate CAIII expression in the kidney. These antibodies did not detect any specific signal with Car3 KO kidney samples, whereas anti-CAII antibodies recognized the appropriate isoform in all samples (Figure 3c ). The distinction between CAII and CAIII isoforms was facilitated by their different electrophoretic mobility in 14% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with CAIII showing a slightly faster migration pattern (B27 kDa) than CAII (B29 kDa) (Figure 3d ). Using these antibodies, we confirmed the specific, fourfold upregulation of CAIII in ClC-5-deficient kidneys, contrasting with the lack of changes in CAII expression (Figure 3e and f). Similar results were obtained by using a monoclonal antibody against CAIII (data not shown).
Immunoblotting analyses detected a specific excretion of CAIII in urine samples from Clcn5 Y/À mice ( Figure 4a ) and in the urine of three unrelated patients with Dent's disease (Figure 4b ). It must be noted that CAIII was detected in simple, non-centrifuged urine samples and that variable levels of CAII could also be detected in such samples, irrespective of the genotype and CAIII levels (data not shown). Thus, CAIII expression is significantly and specifically increased in ClC-5-deficient kidneys, and CAIII is detected in the urine of mice and patients lacking ClC-5.
Cellular and subcellular distribution of CAIII in mouse kidney
In normal kidney, a weak immunoreactive signal for CAIII was observed in a subset of PT cells located in the outer cortex, identified by their apical reactivity for the E1 subunit of the V-ATPase (Figure 5a Immunogold analyses showed that in normal kidney cortex, CAIII distribution was mainly cytosolic, also including the apical brush border microvilli (Figure 6a 14 Thus, CAIII is essentially distributed in the cytosol of a subset of PT cells in the outer cortex of normal mouse kidney. The loss of ClC-5 causes a significant increase of CAIII expression in PT cells of both outer and inner cortices, with a similar subcellular localization. 
Upregulation of CAIII in human Dent's disease kidney samples
We investigated CAIII expression in two kidney cortex samples from the end-stage kidney of a patient with Dent's disease owing to the G506E mutation of CLCN5. 3 CAIII was upregulated at both mRNA and protein levels in these samples vs four end-stage kidney samples taken as controls (Figure 7a and c). Real-time RT-PCR studies also showed an induction of PCNA and thioredoxin expression in Dent kidney samples (Figure 7b ). Despite tissue damage due to end-stage renal disease, the expression of CAIII could be located in PT cells, identified by co-staining with aquaporin-1 ( Figure 7d ). CAII was also apparently upregulated in Dent kidney samples, potentially related to metabolic acidosis. The CAII induction was not observed in mice lacking ClC-5 ( Figure 3 ), which have no renal failure. 7 Although restricted to a single human kidney, these results correlate with the detection of CAIII in the urine of three other patients with Dent's disease and normal renal function ( Figure 4b ). They support the hypothesis that the loss of ClC-5 in the kidney is associated with proliferation, protection against oxidative damage, and induction of CAIII in PT cells.
Expression of CAIII mRNA in distinct mouse models of PT dysfunction
To clarify whether CAIII induction was specifically caused by ClC-5 inactivation or participated in a common cellular response to PT dysfunction, CAIII mRNA expression was investigated in two additional mouse models of renal Fanconi syndrome, namely, the megalin-and cystinosin-deficient mice. These models can be distinguished from each other by the severity of PT defects. 10, 15 The expression of CAIII mRNA was significantly increased in the kidneys of mice lacking megalin (262 ± 22% of WT level, n ¼ 3), whereas no changes were observed in the Ctns KO samples. Moreover, immunoblotting analyses detected a specific excretion of CAIII in the urine of mice lacking megalin (Figure 4c ).
Induction of CAIII expression in PT cells exposed to H 2 O 2
The HK-2 cell line is a well-established model for normal human PT cells. 16 Exposure of HK-2 cells to H 2 O 2 1 mM induced a significant increase in CAIII mRNA expression as early as 3 h postincubation, with a maximal level observed at 6 h. Immunoblotting analyses showed an early and stable induction of CAIII from 6 h postincubation with H 2 O 2 ( Figure 8) . Similarly, exposure of OK cells to H 2 O 2 0.3 mM was associated with an increased expression of CAIII from 6 h postincubation (data not shown). These data demonstrate that PT cells rapidly increase their endogenous expression of CAIII in response to oxidative conditions.
DISCUSSION
We show here that the functional loss of ClC-5, taken as a paradigm of inherited PT dysfunction in mouse and man, is associated with higher cell turnover and increased cellular response to oxidant damage, as well as a major upregulation of CAIII, a CA isoform with no established role in the kidney.
Studies in cultured PT cells suggest that the induction of CAIII may be part of a cellular response to oxidative damage.
Owing to their intense reabsorptive activity involving active transport processes, the epithelial cells lining the PT are particularly vulnerable to injury. However, in contrast to the brain and heart, the PT cells can recover from an ischemic or toxic insult. After cell death by necrosis and apoptosis, the surviving cells dedifferentiate and proliferate to eventually replace the injured cells and restore tubular integrity. 17 Our studies reveal that a similar process occurs as a response to a chronic injury, that is, inherited renal Fanconi syndrome in mouse and man. The proliferative activity of PT cells, assessed by using antibodies to cell proliferation-associated nuclear proteins PCNA and KI-67, was almost fourfold increased, with the involvement of the G 1 cell cycle kinase being suggested by the upregulated cyclin E. Furthermore, PT cells underwent dedifferentiation, as indicated by the expression of osteopontin and the mesodermal marker CAIII (see below). These modifications occurred at a time when no visible alterations in PT cell morphology or renal failure were observed in ClC-5 KO mice, 7 and neither was there any change in the apoptotic rate.
The increased production of superoxide anion and the induction of type I superoxide dismutase and thioredoxin point to increased oxidative stress and solicitation of cell oxidative defenses in ClC-5 KO kidneys. Thioredoxin was also increased in a human kidney lacking functional ClC-5. Oxidative stress has also been documented in PT lesions induced by nephrotoxic compounds, such as cisplatin and heavy metals, 18, 19 as well as in PT cells derived from patients with a renal Fanconi syndrome due to cystinosis. 11 These disorders have in common an alteration of the receptormediated endocytic uptake of albumin and LMW proteins, and the possibility of a link between oxidative stress and defective endocytosis could be raised. The endocytic defect caused by the loss of ClC-5 is reflected in vivo by a selective depletion of megalin (and its partner cubilin) from the brush border in the absence of morphological lesion. 6, 8 Recently, Guggino et al. 20 suggested that megalin could act as a sensor of albumin and that a decrease in its plasma membrane expression could reduce protein kinase B activity and alter the survival pathway involving phosphorylation of Bad in cultured PT cells. The generalized trafficking defect in PT cells lacking ClC-5 8 could also impair the translocation/ activation of protein kinase B, further reducing defense against cytotoxicity. Furthermore, albumin is known to exert a potent survival activity in mouse PT cells, most likely through scavenging of reactive oxygen species, 21 so that a reduced capacity of albumin uptake may be deleterious. In contrast, excessive albumin endocytosis also promotes H 2 O 2 generation in PT cells. 22 Thus, the link between oxidative stress and defective endocytosis remains speculative, and the two events could independently reflect the multiple changes induced by the loss of ClC-5 in PT cells.
At least 15 different CA isoforms with 11 catalytically active isozymes have been described in mammals, with þ / þ and Lrp2 À/À (megalin) mice (n ¼ 3 pairs of mice) were loaded, according to creatinine concentration, on 14% PAGE, blotted onto nitrocellulose, and incubated with anti-CAIII antibodies (1/1000). CAIII is specifically detected in megalin-deficient mouse urine.
distinct kinetic properties and tissue distribution. 12, 23, 24 The cytosolic type II and membrane-bound type IV represent the two major CA isoforms in the kidney, located in PT cells, where they participate in H þ secretion, HCO 3 À reabsorption, and NaCl homeostasis. CAII is also present in the intercalated cells of the collecting duct, where it ensures net urinary acidification. Two other CA isozymes (CAXIII and CAXIV) have been located in the mouse kidney, but their specific role remains unknown. 12 The cytosolic CAIII isoform is characterized by its resistance to sulfonamide inhibitors and its very low CO 2 hydration ability (B2% of CAII activity) due to specific residues in the active site. 24, 25 CAIII is abundantly expressed in the cytosol of skeletal muscle cells, adipocytes, and hepatocytes. 26 Trace amounts of CAIII have been previously identified by radioimmunoassay in the rat kidney, 27 but no role for this isoform has ever been mentioned. 12 CAIII is known to function in an oxidizing environment, 28 which is relevant when considering the oxidative stress evidenced in mouse and human PT cells. Two reactive sulfhydryl groups of CAIII are rapidly S-thiolated by glutathione, after exposure to oxidative conditions, and dethiolated by glutaredoxin-and thioredoxin-like reactions. 29 CAIII may also play a protective role against H 2 O 2 -induced apoptosis, as NIH/3T3 cells overexpressing CAIII grow faster and are more resistant to cytotoxic concentrations of H 2 O 2 than control cells. 30 It has been suggested that CAIII functions as percarbonic acid anhydrase, which would mediate H 2 O 2 þ CO 2 2H 2 CO 4 detoxification. 26 The possibility that CAIII may function as an oxyradical scavenger in PT cells exposed to oxidative stress is supported by our studies in HK-2 and OK cells exposed to H 2 O 2 . Further studies should take advantage of the Car3 KO mice 26 to verify whether this role can be established in vivo.
What could be the mechanism of CAIII induction in PT cells? Androgens regulate CAIII expression in the liver, 31 but we did not observe gender-dependent changes in CAIII mRNA expression in the kidney (data not shown). Thyroidectomy is known to increase CAIII concentration in rat muscle, 32 which could be relevant, as ClC-5 is involved in thyroid endocytosis. 33 However, ClC-5 KO mice develop a euthyroid goiter, without alterations in circulating T4 and thyroid-stimulating hormone levels. 33 Specific transcription factors may also regulate the transcription of CAIII in PT cells. For instance, in silico analyses revealed several potential hepatocyte nuclear factor 1 (HNF1) binding sites in the promoter of the Car3 gene, and mice lacking HNF1a are characterized by a decreased renal expression of CAIII (F Jouret et al., unpublished observations).
The selective detection of CAIII in urine samples of mice and patients lacking ClC-5 and other models of PT dysfunction suggests that it may represent a useful biomarker of renal Fanconi syndrome. As compared with traditional markers, such as LMW proteins (for example, b2-microglobulin), which are produced outside the kidney, filtered but not reabsorbed owing to defective PT endocytosis, or PT cell components (such as N-acetyl-b-glucosaminidase) that appear in the urine in case of structural alterations, CAIII in the urine may directly reflect a state of cellular dysfunction, without changes in renal function or morphology. Furthermore, the upregulation of CAIII is organ-and segment-specific, and it is clearly conserved in mouse and man. Considering that CAIII is an early mesodermal marker, 34 it may reflect cell dedifferentiation along with other genes encoding growth and transcription factors that recapitulate the expression pattern seen during nephrogenesis. 17 Further investigations are necessary to substantiate the role of CAIII in other types of inherited or acquired PT dysfunction.
MATERIALS AND METHODS Mouse models
Experiments were conducted on mice invalidated for Clcn5;
7 Lrp2 (megalin); 10 Ctns; 15 or Car3. 26 Mice lacking megalin in the kidney exhibit defective PT endocytosis, resulting in osteopathy and metabolic defects, 10 whereas the Ctns KO mice present no signs of proximal tubulopathy despite severe PT defects in infantile cystinosis. 15 The mice were housed in metabolic cages overnight with ad libitum access to food and drinking water. Urine was collected in ice-cold Complete protease inhibitors (Roche, Vilvoorde, Belgium), total volume was measured, and the samples immediately frozen and kept at À80 1C. An aliquot was used to measure the levels of creatinine by standard methods (Eastman Kodak Company, Rochester, NY, USA). All studies were in accordance with the National Institutes of Health (NIH) guidelines for the care and use of laboratory animals and approved by the Committee for Animal Rights of the UCL.
Human samples
Two samples (outer cortex) from one end-stage kidney were obtained at the time of nephrectomy in a patient with Dent's disease due to the G506E mutation in CLCN5.
3 Four cortical samples from end-stage kidneys (chronic interstitial nephritis) removed during renal transplantation were used as controls. The kidney samples were frozen in liquid nitrogen or fixed in 4% formaldehyde. We obtained urine samples (second morning miction) from three unrelated patients with Dent's disease harboring nonsense mutations (S203X, R637X, and R648X) in CLCN5 and from their asymptomatic carrier mothers. All patients (aged 7, 15, and 13 years, respectively) had LMW proteinuria and hypercalciuria but no renal failure. The use of these samples has been approved by the Ethical Review Board of the UCL.
PT cell lines
The human kidney (HK-2) and opossum kidney (OK) cell lines were cultured as described. 16 After 24 h serum deprivation, subcultures of HK-2 (passage 12) and OK cells (passage 111) were treated with H 2 O 2 (1 or 0.3 mM, respectively) for 1-14 h. Cell pellets were harvested and kept at -80 1C before mRNA and protein extraction.
RNA extraction and double-strand cDNA synthesis Total RNA was extracted using Trizol (Invitrogen, Merelbeke, Belgium). For AFLP, poly(A) þ RNA was prepared from total RNA using Dynabeads Oligo(dT) 25 (Invitrogen). First-strand cDNA was synthesized from 500 ng of poly(A) þ RNA using SuperScript II RNase H À Reverse Transcriptase (Invitrogen). Double-strand cDNA was synthesized using T4 DNA Polymerase and purified using QIAquick Extraction Kit (Qiagen, Venlo, The Netherlands).
AFLP reactions
The AFLP protocol was performed as described previously. 35 cDNA samples were digested with EcoRI and MseI (Fermentas, Vilnius, Lithuania) and ligated to EcoRI and MseI double-strand adapters (Supplementary Table S1 ) for 2 h at 20 1C. The restriction fragments with ligated adapters were diluted (10 Â ) with TE buffer (100 mM Tris-HCl, 10 mM EDTA, pH 8.0) and used as a template for the pre-amplification reaction, which was performed for 20 cycles (94 1C, 30 s; 56 1C, 1 min; 72 1C, 1 min) using Eco-P0 and Mse-P0 primers. The product was diluted (10 Â ) with TE buffer, and 5 ml was used for selective amplification as follows: 33 cycles including 9 touchdown cycles comprising a decrease of the annealing temperature from 65 to 56 1C, which was maintained for 24 cycles. Twelve primer combinations were used for selective amplification (Eco-PAA and Mse-PAA or Mse-PAC or Mse-PAT; Eco-PAC and Mse-PAA or Mse-PAC or Mse-PAT; Eco-PAG and Mse-PAA or Mse-PAC or Mse-PAT; Eco-PAT and Mse-PAA or Mse-PAC or Mse-PAT) using an iCycler Thermal Cycler (Bio-Rad, Nazareth, Belgium). The amplification products were denatured and separated on sequencing gels (6% polyacrylamide, 6 M urea) that were then dried and exposed to Kodak BioMax film (Amersham Biosciences, Buckinghamshire, UK). The bands of interest were removed from the gel and recovered by PCR. Reamplified cDNAs were visualized on a 1.5% (w/v) agarose gel, subcloned into pGEM-T easy vector (Promega, Leiden, The Netherlands), and sequenced (Genome Express, Meylan, France). Each re-amplified AFLP fragment was analyzed using the BLAST sequence alignment program (http://www.ncbi.nlm.nih.gov/ BLAST/).
Real-time RT-PCR
Total RNA was treated with DNase I (Invitrogen) and reversetranscribed using SuperScript III RNase H À Reverse Transcriptase (Invitrogen). Changes in mRNA expression levels were determined by real-time RT-PCR (iCycler iQ System; Bio-Rad) using SYBR Green I (Invitrogen). 36 Specific primers were designed using Beacon Primer Designer 2.0 (Premier Biosoft International, Palo Alto, CA, USA) (Supplementary Table S2 ). The PCR products were sequenced by Genome Express. The efficiency of each set of primers was determined by dilution curves (Supplementary Table S2) , and the C t differences between the reference (GAPDH, glyceraldehyde-3-phosphate dehydrogenase) and target genes were calculated for each sample of each genotype. The formula used to quantify the relative changes in target over GAPDH mRNAs between the two groups is derived from the 2 ÀDDCt formula as described by Pfaffl. (Figure 3c ), red blood cell ghosts, and epididymis (data not shown).
Protein extraction and Immunoblotting
Cytosolic proteins were extracted from kidney samples as described. 7, 36 Cell lysates were obtained by solubilizing frozen pellets in lysis buffer containing Complete Mini (Roche), followed by sonication and centrifugation at 16 000 g for 1 min at 4 1C. Protein concentrations were determined using bicinchoninic acid protein assay (Pierce, Aalst, Belgium). Tissue and urine samples were thawed on ice, normalized for protein or creatinine levels, diluted in Laemmli buffer, separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10 Â 7 cm, 14% gels) in reducing conditions, and blotted onto nitrocellulose as described. 36 Densitometry analysis was performed with a Canon CanoScan 8000F using the NIH Image V1.60 software.
Immunostaining and immunogold labeling
Kidney samples were fixed in 4% formaldehyde in 0.1 M phosphate buffer, pH 7.4, and embedded in paraffin. Immunostaining was performed on 6 mm sections using avidin-biotin peroxidase (Vectastain Elite; Vector Laboratories, Labconsult, Brussels, Belgium) and aminoethylcarbazole. 37 Controls without primary antibody or with non-immune IgG (Vector Laboratories) were negative. Counting of PCNA-, Ki67-, and CAIII-positive PT cells was blindly performed on five different cortex areas in four pairs of Clcn5 Y/À vs Clcn5 Y/ þ kidneys. For immunogold labeling, kidneys were fixed by retrograde perfusion with 2% formaldehyde in 0.1 M sodium cacodylate buffer, pH 7.2, and 70-90 nm cryosections were obtained with an FCS Reichert Ultracut S cryo-ultramicrotome as described. 38 Sections were incubated with rabbit anti-CAIII at 4 1C overnight, followed by incubation for 1 h with 10 nM goat anti-rabbit gold particles (BioCell, Cardiff, UK). The cryosections were embedded in methylcellulose containing 0.3% uranyl acetate and studied in a Philips CM100 electron microscope. Controls with secondary antibody alone or with nonspecific rabbit serum were negative.
Detection of superoxide anion (O 2
K-) generation The in situ production of O 2 K-in kidney sections was assessed using the hydroethidine fluorescence method and detection of fluorescent ethidium bromide as described. 39 Briefly, kidney cryosections were incubated with 50 ml of 2 Â 10 À6 M HB solution (Invitrogen) in water at 37 1C for 30 min in a light-protected and humidified chamber. Red fluorescence from hydroethidine-treated samples was measured during 5 ms using the software KS400 (Zeiss, Zaventem, Belgium) through a Zeiss Axiovert S100 microscope equipped with an Axiocam camera.
Statistics
Results are expressed as means±s.d. Comparisons between groups were made by Student's unpaired t-tests. The significance level was set at Po0.05 . 0   T0  T1  T2  T3  T4  T6  T8 
